BIPEHNCT06394206
Benefit of a Hospital Intervention in Patients With Hepatic Steatosis
StatusWithdrawn
PhaseNot applicable
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗
Stopped Withdrawn before enrolling Sponsor's reason: Funding issues Show 4 more changesShow less
- Enrollment target: estimated 86 to confirmed 0
- Eligibility criteria expanded, about 9 words
- Secondary endpoints: details revised at 5 of 12 entries
- Site contact updated
- Notable Primary and study completion dates: Dec 2026 to Dec 2027
- Start date: Dec 2024 to Dec 2025
- Notable Primary and study completion dates: May 2026 to Dec 2026
- Start date: May 2024 to Dec 2024
- Study First Submitted
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
Endpoints
Primary
Discharge criteria from the gastroenterology clinic
Timeframe: 1 year
Secondary (12)
Discharge from the gastroenterology clinic after achieving metabolic control goals
Change on Test de Owliver
Change on liver enzymes
Change on total cholesterol
Change on LDL- cholesterol
Show 7 moreShow less
Change on HDL- cholesterol
Change on triglycerides
Change on Fibrosis-4 Index
Change on Hepatic Fibrosis
Glycated hemoglobin
Insulin resistance
Body Mass Index
Arms and interventions
Specialized UnitExperimental
This group of participants will be visited in the specialized consultation and will continue to receive the rest of their follow-up visits.
Usual Follow-UpActive comparator
This group of participants will undergo their usual follow-up visits but will not be visited in the specialized consultation.
Other: Specialized Unit, Usual Follow-Up
Sites
1 site in 1 country
- Consorci Sanitari Alt Penedes i GarrafSant Pere de Ribes, Barcelona, Spain